All treatments
InjectionLongevityIn stock

NAD+ injection

A provider-reviewed NAD+ injection format for longevity programs that want a higher-touch offer with consults, refill review, and recurring membership revenue.

Launch this programSee the stack
NAD+ Injection
Cadence
Provider-directed
Program fit
Premium add-on
Format
Injectable NAD+ protocol
Workflow
Consult-led onboarding and refill review
Rx required
Yes — licensed provider review
Guardrail
Sterile sourcing and pharmacy QA matter
About the protocol

An injectable NAD+ option for higher-touch longevity programs

NAD+ is a coenzyme involved in cellular energy metabolism. Clinics sometimes offer compounded NAD+ injection protocols as part of longevity memberships and wellness lineups. Because the human evidence base is still early and formulations vary by pharmacy, the strongest programs position it with careful screening, conservative messaging, and structured follow-up.

  • Uses NAD+, a coenzyme involved in cellular metabolic processes
  • Fits consult-led programs that already support training, check-ins, and refill review
  • Lets providers tailor cadence and continuation decisions to the individual patient
  • Best framed as a provider-directed wellness protocol, not a guaranteed-outcomes therapy
Mechanism
NAD+ participates in redox reactions and other core cellular processes.
Delivery
Injectable format for clinics that want a higher-touch patient workflow.
Sourcing
Sterile compounding workflow and ingredient quality are central to launch readiness.
Oversight
Every order should stay behind provider review, pharmacy routing, and refill checkpoints.
Program design

Best positioned as a premium, supervised add-on

Injection programs are usually not the lightest-weight front-door offer. They work best when your team already has intake, provider review, and refill operations in place for a consult-led longevity membership.

Premium membership fit
Useful when you want a higher-touch format that can support stronger ARPU than a simple daily product.
Provider involvement
Works best when clinicians can screen patients, set expectations, and decide whether to renew or pause.
Messaging guardrails
Keep the page compliant and expectation-setting clear because human evidence for NAD+ interventions is still developing.

FDA published a reminder on October 30, 2024 that sterile compounded NAD+ products depend on appropriate ingredient sourcing and quality controls.

Launch flow

A simple launch flow for injectable NAD+

Exact strength and cadence can vary by clinician, pharmacy, and patient. Most teams keep the launch flow simple and use provider review to decide how the protocol is started and renewed.

  1. 1
    Step 1
    Intake and screening
    Collect goals, medication history, contraindications, and state/licensure fit before routing to a provider.
  2. 2
    Step 2
    Guided start
    Approve the order, teach administration, and set refill timing with clear patient instructions.
  3. 3
    Step 3
    Refill review
    Use follow-ups to assess fit, tolerability, adherence, and whether the protocol should continue, pause, or change.
Sterile compounding workflow and ingredient quality are central to launch readiness — the FDA's October 30, 2024 reminder on NAD+ sourcing is a useful anchor for your operator playbook.
Format comparison

Interactive operator view

Use these charts to compare how the injectable format usually behaves operationally versus NAD+ nasal spray. They are meant for program planning, not as clinical-outcome claims.

Format comparison by operator dimension
Hover to compare injection versus nasal spray.
InjectionNasal spray
Strongest current edge
Provider oversight
Injection scores 94/100 on this dimension.
Clearest difference
Provider oversight
This is where the two NAD+ formats separate the most in program design terms.
Needs the most support
Patient convenience
This is the weakest current score in the comparison, so it is the area most likely to need extra workflow design.

Illustrative operator-planning view based on format complexity, provider touchpoints, and refill behavior. Not a statement of safety or efficacy.

The Turbopills stack for this program

Everything you need to run an NAD+ injection program

Use your own brand, your own providers, and your own pricing. The platform brings the intake, subscriptions, refill workflows, and the operator console that tie them all together in one backend.

Product website & ad landing pages
Turbopills AI Studio — ad images & videos
Beta
Dynamic intake forms
Billing & subscriptions
Provider review & e-Rx
Pharmacy order routing
Refills & auto-ship
Patient communications
Experiments & A/B tests
Beta
Ready to launch

Add an NAD+ injection offer without building the ops from scratch.

The platform ships the intake, billing, refill logic, and patient communications your program runs on. Plug in your licensed providers and pharmacy partners, and launch without stitching together vendors.

Talk to our teamBrowse treatments

Marketing and educational content only. Clinical details on this page are summarized from publicly available sources to help operators scope a program — they are not medical advice, dosing instructions, or a recommendation for any individual patient. Real patient care requires a licensed provider and a compliant pharmacy partner; Turbopills provides the software that helps brands run the program around them.

Related

Other NAD+ formats